共 50 条
- [1] Etrasimod for ulcerative colitis LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (08): : 708 - 708
- [2] Etrasimod (Velsipity) for Ulcerative Colitis MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1690): : 187 - 189
- [6] Hepatic Impact of Etrasimod for Treatment of Moderately to Severely Active Ulcerative Colitis: An Integrated Safety Summary From the Etrasimod Ulcerative Colitis Clinical Program AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S816 - S817
- [7] Etrasimod for ulcerative colitis: evaluating phase III results Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 762 - 763
- [8] Impact of Etrasimod on Blood Pressure and Hypertension: Data From the Etrasimod Ulcerative Colitis Clinical Program AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S675 - S675
- [9] Statement on the Benefit Assessment of Etrasimod (ulcerative Colitis, ≥ 16 Years) ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (10): : 1857 - 1861
- [10] The sphingosine-1-phosphate receptor agonist etrasimod in ulcerative colitis LANCET, 2023, 401 (10383): : 1132 - 1133